Peer-influenced content. Sources you trust. No registration required. This is HCN.
News Medical
Erucamide, a naturally occurring lipid molecule, declined as photoreceptors deteriorated in preclinical retinal degeneration models, and restoring it via nanoparticle delivery slowed aspects of tissue breakdown without reversing damage.
Neurology June 29th 2026
Eyewire+
Bayer agreed to acquire Perfuse Therapeutics in a deal valued at up to $2.45 billion, gaining full rights to a phase 2 endothelin receptor antagonist for glaucoma and diabetic retinopathy.
Ophthalmology May 18th 2026
Glaucoma Physician
“Despite more than 100 years of lowering intraocular pressure… too many patients still go blind.” — Eugene de Juan Jr, MD, UCSF
Neurology March 9th 2026
ALS News Today
“A 65% reduction in the risk of death and a statistically significant extension in median survival of over 14 months represent a clinically meaningful benefit of notable magnitude in ALS.” — Alon Ben-Noon, CEO, Neurosense Therapeutics
Neurology March 5th 2026
“Creatine influences the exercise-dependent secretion of neurotransmitters and cytokines like serotonin and dopamine, which improve neural function and promote neuroplasticity.”
Family Medicine/General Practice August 5th 2025
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS